To the Editor:

The administration of supplemental oxygen is one of the ubiquitous interventions in the intensive care unit (ICU) and can be life-saving for mechanically ventilated patients \[[@CR1]\]. However, excessive oxygen could be detrimental. Recently, several studies comparing the effect of conservative and liberal oxygen therapy for critically ill patients did not achieve consistent results \[[@CR2], [@CR3]\]. Furthermore, in patients with acute respiratory distress syndrome (ARDS), conservative oxygen therapy even had a signal of increased mortality and mesenteric ischemia \[[@CR4]\]. Of note, the target oxygen levels in these studies were not the same. It is of paramount importance to elucidate oxygen targets to guide future research. In the present study, with a big database, we aimed to evaluate the association of the proportion of time within arterial oxygen saturation (SpO~2~) with hospital mortality in an ICU population with mechanical ventilation (MV).

This study used data stored in the eICU ([eicu-crd.mit.edu](https://eicu-crd.mit.edu/)) database \[[@CR5]\]. Adult patients admitted to ICU for the first time with MV during the first 24 h were included. The main exposure was SpO~2~, which was generally interfaced from bedside vital sign monitors as the 5-min median value. Thirteen categories of SpO~2~ were generated, which were ≤ 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, and 100%. The proportion of time spent (PTS) in different SpO~2~ categories for each patient was defined as the percentage of the summarized time in each different SpO~2~ category divided by total time. Thus, during the first 24 h, patients had SpO~2~ values that fell in the 13 categories and for each patient PTS in each of the predefined categories ranged from 0 to 100%. PTS was examined as both a continuous and categorical variable. The primary outcome was hospital mortality. Multivariable logistic regression models including PTS within each of these SpO~2~ categories along with the confounders were used to analyze the association of PTS-SpO~2~ with mortality outcome.

A total of 25,669 patients from 186 hospitals were included (Table [1](#Tab1){ref-type="table"}), including 21,326 (83%) survivors and 4343 (17%) non-survivors. The median fraction of inspired oxygen was 45% (IQR, 43\~60%) and the median duration of MV was 3 days (IQR, 2\~5 days). After adjusted for confounders, PTS-SpO~2~ of ≤ 88%, 89%, 90%, 91%, 92%, 93%, and 100% were associated with a higher odds ratio for hospital mortality; PTS-SpO~2~ of 95%, 96%, 97%, 98%, and 99% were associated with a lower odds ratio; and PTS-SpO~2~ of 94% was not associated with hospital mortality (Fig. [1](#Fig1){ref-type="fig"}a). Based on the results, SpO~2~ was divided into three categories (≤ 94%, 95--99%, and 100%). PTS-SpO~2~ within categories of ≤ 94% (*p* \< 0.001) and 100% (*p* \< 0.001) were associated with a higher risk of hospital mortality, whereas an inverse trend was observed between PTS-SpO~2~ of 95--99% (*p* \< 0.001) and hospital mortality (Fig. [1](#Fig1){ref-type="fig"}b). Table 1Characteristics of study patients between survivors and non-survivorsVariablesTotal (*n* = 25, 669)Survivors (*n* = 21, 326)Non-survivors (*n* = 4343)*p* valueAge, years (median, \[IQR\])65 (54, 75)65 (53, 74)70 (58, 79)\< 0.001Gender, male (*n* (%))13,933 (54)11,561 (54)2372 (55)0.636BMI (median, \[IQR\])28.3 (23.9, 34.4)28.5 (24.1, 34.6)27.4 (23.2, 33.1)\< 0.001Comorbidities (*n* (%)) Hypertension13,533 (53)11,216 (53)2317 (53)0.371 Diabetes mellitus6149 (24)5173 (24)976 (22)0.013 COPD5870 (23)4919 (23)951 (22)0.099 Heart failure5011 (20)4110 (19)901 (21)0.027 Cirrhosis443 (2)335 (2)108 (2)\< 0.001 Cancer411 (2)269 (1)142 (3)\< 0.001 Chronic renal failure3585 (14)2871 (13)714 (16)\< 0.001ICU types (*n* (%))\< 0.001 Med-Surg ICU13,737 (54)11,477 (54)2260 (52) Cardiac ICU1636 (6)1216 (6)420 (10) CCU-CTICU2162 (8)1843 (9)319 (7) CSICU889 (3)768 (4)121 (3) CTICU1179 (5)1083 (5)96 (2) MICU2587 (10)2088 (10)499 (11) Neuro ICU1643 (6)1295 (6)348 (8) SICU1836 (7)1556 (7)280 (6)Admission diagnosis (*n* (%))\< 0.001 Respiratory5910 (23)5106 (24)804 (19) Sepsis3660 (14)2856 (13)804 (19) Cardiac surgery3035 (12)2847 (14)88 (2) Non-cardiac surgery2495 (10)2207 (10)288 (7) Neurological2560 (10)1985 (9)575 (13) Cardiovascular2079 (8)1783 (8)296 (7) Cardiac arrest2143 (8)1149 (5)994 (23) Trauma1179 (5)986 (5)193 (4) Gastrointestinal461 (2)378 (2)83 (2) Others2147 (8)1929 (9)218 (5)TWM-PaO~2~, mmHg (*n* (%))\< 0.001 \< 60622 (2)480 (2)142 (3) 60--12010,593 (41)8832 (41)1761 (41) 120--3008226 (32)6691 (31)1535 (35) \> 300579 (2)453 (2)126 (3) Missing (*n* (%))5649 (22)4870 (23)779 (18)TWM-PaCO~2~, mmHg (*n* (%))\< 0.001 \< 354420 (17)3336 (16)1084 (25) 35--459555 (37)8041 (38)1514 (35) \> 455849 (23)4928 (23)921 (21) Missing (*n* (%))5845 (23)5021 (24)824 (19)TWM-pH (*n* (%))\< 0.001 \< 7.356868 (27)5311 (25)1557 (36) 7.35--7.4510,085 (39)8635 (40)1450 (33) \> 7.452626 (10)2136 (10)490 (11) Missing (*n* (%))6090 (24)5244 (25)846 (19)TWM-FiO~2~, % (median, \[IQR\])45 (43, 60)45 (42, 59)50 (45, 75)\< 0.001APACHE IV (median, \[IQR\])68 (50, 89)63 (48, 83)92 (72, 115)\< 0.001SOFA (median, \[IQR\])6 (4, 8)6 (4, 8)8 (6, 11)\< 0.001Vasopressors (*n* (%))5734 (22)4135 (19)1599 (37)\< 0.001Dialysis (*n* (%))976 (4)802 (4)174 (4)0.466Ventilation days (*n* (%))3 (2, 5)3 (2, 4)4 (2, 7)\< 0.001*IQR* interquartile range, *BMI* body mass index, *COPD* chronic obstructive pulmonary disease, *ICU* intensive care unit, *CCU* coronary care unit, *CTICU* cardiothoracic ICU, *CSICU* cardiac surgery ICU, *MICU* medical ICU, *SICU* surgical ICU, *TWM* time-weighted mean, *SpO*~*2*~ peripheral oxygen saturation, *PaO*~*2*~ partial pressure of arterial oxygen, *PaCO*~*2*~ partial pressure of arterial carbon dioxide, *FiO*~*2*~ fraction of inspired oxygen, *APACHE* Acute Physiology and Chronic Health Evaluation, *SOFA* sequential organ failure assessmentFig. 1**a** Adjusted odds ratio for hospital mortality according to different SpO~2~ categories. The proportion of time spent in thirteen different SpO~2~ categories (≤ 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, and 100%) was considered as a continuous variable, ranging from 0 to 100%, and was included in separate multivariable regression models along with the confounders. In total, 13 models were created. The adjusted odds ratio for each SpO~2~ category and 95% confidence intervals (error bars) were calculated after adjusting for age, body mass index (obesity or non-obesity), admission diagnosis, comorbidities (diabetes mellitus, cancer), time-weighted mean FiO~2~, time-weighted mean pH, time-weighted mean PaCO~2~, sequential organ failure assessment score (not including the respiratory part), and use of dialysis. An odds ratio is calculated per 5% increase in time in each given category. SpO~2~, arterial oxygen saturation; FiO~2~, fraction of inspired oxygen; PaCO~2~, partial pressure of arterial carbon dioxide. **b** Observed hospital mortality of four predefined time ranges (0--25%, 25--50%, 50--75%, and 75--100%) spent in three different SpO~2~ categories (≤ 94%, 95--99%, and 100%). Figures on each histogram column represented the crude hospital mortality

The result of the present study was partially consistent with the British Thoracic Society guideline, which recommended the target of SpO~2~ 94--98% \[[@CR6]\]. In addition, the result could partly account for the discrepancy of the recent clinical trials of oxygen therapy, which adopted different target oxygen levels \[[@CR2]--[@CR4]\]. Despite several limitations to our study (e.g., retrospective design, potential residual confounders, unvalidated data from monitors, relatively short study period, lack of mode of MV, and missing data), our study provided observational evidence for a SpO~2~ target range of 95--99% with real-world data. Further studies are warranted to validate the particular target.

In conclusion, the proportion of time spent in oxygen saturation 95--99% is associated with reduced mortality in critically ill patients with mechanical ventilation. These findings may have implications for the design of future trials of oxygen therapy.
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